“We are projecting rate increases in the range of six to 7% in aggregate for the year, but that will continue to be below our”

In context

“caid business, I think you made reference to getting a little bit of rate relief. So was hoping you could speak to oneone rates that you're seeing and maybe contrast that to the rates you were seeing in 2025? And in general, if the rates are coming in a bit better seems like there's not gonna be any material impact from early starts to work requirements if you kinda revisited your margin assumption for the Medicaid business at all in 2026? Thanks. Wayne DeVeydt: Thanks, Stephen, for the question. I'll give you kind of an overview on where we are in rates. For 2026, our view remains unchanged. In terms of overall performance. Our Medicaid business for Medicaid we do expect some margin contraction. Due to the ongoing dislocation of rates and continued elevated medical trends. medical trend. We are projecting rate increases in the range of six to 7% in aggregate for the year, but that will continue to be below our And we do expect some, membership contraction as we continue to manage the business. For January 1, our rates are somewhat in line with our expectations. And, again, we expect our rates to range between six to 7% for the year. As we think about 2026. Thanks for the question. Next question, please. Operator: And our next question comes from Lisa Gill with JPMorgan. Lisa Gill: Thanks very much and good I wanted to ask a couple of questions on OptumRx side. First, Wayne, you made a comment that due to Part D, we're going to see earnings more first half driven Can you talk about the changes around the subsidies and the impact that we have on Part D And then secondly, when we think about OptumRx, you talked about the member contractions because of what happened on The United side, but 800 new”